Merrion Pharmaceuticals announces liquidation plan

Merrion Pharmaceuticals announces liquidation plan
Dr John Fox to leave Merrion Pharmaceuticals after EGM. PIcture: Feargal Ward

Company could have around €4.5m to distribute to shareholders

The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.

Following the sale of its intellectual property assets to drug giant Novo Nordisk and changes to the licence agreements between the two companies last year, Merrion became an investment company with a focus on the healthcare sector.

In a statement today, however, Merrion said...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post